Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 175
- Registration Number
- NCT00737282
- Locations
- 🇺🇸
Lynn Institute of the Ozarks, Little Rock, Arkansas, United States
🇺🇸York Clinical Consulting, Marrero, Louisiana, United States
🇺🇸Female Pelvic Medicine, Grand Rapids, Michigan, United States
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 77
- Registration Number
- NCT00735553
- Locations
- 🇺🇸
Genova Clinical Research, Inc., Tucson, Arizona, United States
🇺🇸Women's Health Research, Phoenix, Arizona, United States
🇺🇸Women's Health Care at Frost Steet, San Diego, California, United States
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00706719
- Locations
- 🇺🇸
University Urology Associates, New York, New York, United States
🇺🇸MAZE Labs, Purchase, New York, United States
Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT00702702
- Locations
- 🇺🇸
Central Brooklyn Medical Group (eCast), Brooklyn, New York, United States
🇺🇸Phoenix Women's Center (eCast), College Park, Georgia, United States
🇺🇸Advanced Research Associates, Corpus Christi, Texas, United States
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
- Conditions
- Interventions
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT00683917
- Locations
- 🇺🇸
Physician Care Clinical Research, Sarasota, Florida, United States
🇲🇽Centro de Estudios Cientificos y Clinicos Pharma, S.A. de C.V. (CECYC-Pharma), Mexico City, Federal District, Mexico
🇺🇸West Houston Clinical Research Services, Houston, Texas, United States
Proellex® Pharmacokinetic Bridging Study II
- Conditions
- Interventions
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00620503
- Locations
- 🇺🇸
Healthcare Discoveries Inc., San Antonio, Texas, United States
A Safety and Pharmacokinetic Study of Proellex®
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00619385
- Locations
- 🇺🇸
Healthcare Discoveries Inc., San Antonio, Texas, United States
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
- Conditions
- Interventions
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT00556075
- Locations
- 🇺🇸
Lynn Institute of the Ozarks, Little Rock, Arkansas, United States
🇺🇸Medical Associates, Dubuque, Iowa, United States
🇺🇸Medical Center for Clinical Research, San Diego, California, United States